SE510587C2 - Koncentrat för dialyslösning och användning därav - Google Patents

Koncentrat för dialyslösning och användning därav

Info

Publication number: SE510587C2
Authority: SE; Sweden
Prior art keywords: concentration; glucose; concentrate; gluconic acid; acid
Prior art date: 1997-10-07

Application number

SE9703650A

Other languages

English (en)

Swedish (sv)

Other versions

SE9703650D0 (sv

SE9703650L (sv

Inventor

Torbjoern Linden

Lennart Joensson

Stefan Knutsson

Robert Picard

Original Assignee

Gambro Lundia Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-07

Filing date

1997-10-07

Publication date

1999-06-07

1997-10-07 Application filed by Gambro Lundia Ab filed Critical Gambro Lundia Ab

1997-10-07 Priority to SE9703650A priority Critical patent/SE510587C2/sv

1997-10-07 Publication of SE9703650D0 publication Critical patent/SE9703650D0/xx

1998-10-05 Priority to JP2000514633A priority patent/JP4346818B2/ja

1998-10-05 Priority to US09/529,213 priority patent/US6323182B1/en

1998-10-05 Priority to DE69809587T priority patent/DE69809587T2/de

1998-10-05 Priority to PCT/SE1998/001785 priority patent/WO1999017762A1/en

1998-10-05 Priority to AU94689/98A priority patent/AU9468998A/en

1998-10-05 Priority to ES98948026T priority patent/ES2183417T3/es

1998-10-05 Priority to EP98948026A priority patent/EP1033984B1/de

1998-10-05 Priority to AT98948026T priority patent/ATE227985T1/de

1999-04-08 Publication of SE9703650L publication Critical patent/SE9703650L/xx

1999-06-07 Publication of SE510587C2 publication Critical patent/SE510587C2/sv

Links

239000012141 concentrate Substances 0.000 title claims abstract description 48
239000000385 dialysis solution Substances 0.000 title description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 41
239000008103 glucose Substances 0.000 claims abstract description 41
RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims abstract description 38
235000012208 gluconic acid Nutrition 0.000 claims abstract description 35
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims abstract description 34
239000000174 gluconic acid Substances 0.000 claims abstract description 34
238000000502 dialysis Methods 0.000 claims abstract description 10
238000002360 preparation method Methods 0.000 claims abstract 4
239000003978 infusion fluid Substances 0.000 claims abstract 3
239000000243 solution Substances 0.000 claims description 11
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 10
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
RGHNJXZEOKUKBD-KLVWXMOXSA-N L-gluconic acid Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)C(O)=O RGHNJXZEOKUKBD-KLVWXMOXSA-N 0.000 claims 4
238000001631 haemodialysis Methods 0.000 claims 2
230000000322 hemodialysis Effects 0.000 claims 2
238000002615 hemofiltration Methods 0.000 claims 2
229940126601 medicinal product Drugs 0.000 claims 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 7
238000010790 dilution Methods 0.000 abstract description 3
239000012895 dilution Substances 0.000 abstract description 3
239000007864 aqueous solution Substances 0.000 abstract 1
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 66
238000002474 experimental method Methods 0.000 description 25
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
239000002253 acid Substances 0.000 description 11
239000000203 mixture Substances 0.000 description 10
230000000694 effects Effects 0.000 description 8
230000007423 decrease Effects 0.000 description 7
235000002639 sodium chloride Nutrition 0.000 description 7
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
238000010586 diagram Methods 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
239000000126 substance Substances 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 4
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
239000011575 calcium Substances 0.000 description 3
229910052791 calcium Inorganic materials 0.000 description 3
239000011777 magnesium Substances 0.000 description 3
229910052749 magnesium Inorganic materials 0.000 description 3
239000011591 potassium Substances 0.000 description 3
229910052700 potassium Inorganic materials 0.000 description 3
239000001632 sodium acetate Substances 0.000 description 3
235000017281 sodium acetate Nutrition 0.000 description 3
AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
235000012209 glucono delta-lactone Nutrition 0.000 description 2
230000009931 harmful effect Effects 0.000 description 2
239000000176 sodium gluconate Substances 0.000 description 2
235000012207 sodium gluconate Nutrition 0.000 description 2
229940005574 sodium gluconate Drugs 0.000 description 2
238000004448 titration Methods 0.000 description 2
206010068780 Acetate intolerance Diseases 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
UYUXSRADSPPKRZ-UHFFFAOYSA-N D-glucuronic acid gamma-lactone Natural products O=CC(O)C1OC(=O)C(O)C1O UYUXSRADSPPKRZ-UHFFFAOYSA-N 0.000 description 1
UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000032683 aging Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
230000009918 complex formation Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
229940050410 gluconate Drugs 0.000 description 1
229960003681 gluconolactone Drugs 0.000 description 1
229950002441 glucurolactone Drugs 0.000 description 1
-1 glycuronic acid Chemical class 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
238000001802 infusion Methods 0.000 description 1
150000002596 lactones Chemical class 0.000 description 1
230000007774 longterm Effects 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
238000005259 measurement Methods 0.000 description 1
239000002357 osmotic agent Substances 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
External Artificial Organs (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

SE9703650A 1997-10-07 1997-10-07 Koncentrat för dialyslösning och användning därav SE510587C2 (sv)

Priority Applications (9)

Application Number	Priority Date	Filing Date	Title
SE9703650A SE510587C2 (sv)	1997-10-07	1997-10-07	Koncentrat för dialyslösning och användning därav
AT98948026T ATE227985T1 (de)	1997-10-07	1998-10-05	Konzentrat für medizinische lösung und dessen verwendung
PCT/SE1998/001785 WO1999017762A1 (en)	1997-10-07	1998-10-05	Concentrate for medical solution and use thereof
US09/529,213 US6323182B1 (en)	1997-10-07	1998-10-05	Concentrate for medical solution and use thereof
DE69809587T DE69809587T2 (de)	1997-10-07	1998-10-05	Konzentrat für medizinische lösung und dessen verwendung
JP2000514633A JP4346818B2 (ja)	1997-10-07	1998-10-05	医療用溶液の濃縮物及びその使用
AU94689/98A AU9468998A (en)	1997-10-07	1998-10-05	Concentrate for medical solution and use thereof
ES98948026T ES2183417T3 (es)	1997-10-07	1998-10-05	Concentrado para solucion medica y su utilizacion.
EP98948026A EP1033984B1 (de)	1997-10-07	1998-10-05	Konzentrat für medizinische lösung und dessen verwendung

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9703650A SE510587C2 (sv)	1997-10-07	1997-10-07	Koncentrat för dialyslösning och användning därav

Publications (3)

Publication Number	Publication Date
SE9703650D0 SE9703650D0 (sv)	1997-10-07
SE9703650L SE9703650L (sv)	1999-04-08
SE510587C2 true SE510587C2 (sv)	1999-06-07

Family

ID=20408531

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9703650A SE510587C2 (sv)	1997-10-07	1997-10-07	Koncentrat för dialyslösning och användning därav

Country Status (9)

Country	Link
US (1)	US6323182B1 (de)
EP (1)	EP1033984B1 (de)
JP (1)	JP4346818B2 (de)
AT (1)	ATE227985T1 (de)
AU (1)	AU9468998A (de)
DE (1)	DE69809587T2 (de)
ES (1)	ES2183417T3 (de)
SE (1)	SE510587C2 (de)
WO (1)	WO1999017762A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8105258B2 (en)	1999-04-26	2012-01-31	Baxter International Inc.	Citrate anticoagulation system for extracorporeal blood treatments
ATE405277T1 (de)	1999-04-26	2008-09-15	Edwards Lifesciences Ag	Substitutions-infusionflüssigkeit und zitratanticoagulation
US7186420B2 (en)	1999-04-26	2007-03-06	Edwards Lifesciences Corporation	Multi-part substitution infusion fluids and matching anticoagulants
US7445801B2 (en) *	2002-06-07	2008-11-04	Baxter International Inc.	Stable bicarbonate-based solution in a single container
GR1004476B (el) *	2002-12-12	2004-03-05	Ιπποκρατης Αλεξανδρου Γιατζιδης	Γλουκονικο οξυ. ενας νεος ισχυρος και ακινδυνος δεσμευτης για τη διορθωση της υπερφωσφαταιμιας των αρρωστων με τελικη νεφρικη ανεπαρκεια
US20040121982A1 (en) *	2002-12-20	2004-06-24	Leo Martis	Biocompatible dialysis fluids containing icodextrins
US20050276868A1 (en) *	2004-06-10	2005-12-15	Bart Degreve	Bicarbonate-based peritoneal dialysis solutions
US20100247694A1 (en) *	2008-01-31	2010-09-30	Joseph Di Bartolomeo	Composition and method for treament of inflamation and infections of the outer ear canal, nose and paranasal sinuses
US20100051552A1 (en) *	2008-08-28	2010-03-04	Baxter International Inc.	In-line sensors for dialysis applications
DE102010039489A1 (de) *	2010-08-18	2012-02-23	Fresenius Medical Care Deutschland Gmbh	Konzentrat
JP5282923B2 (ja) *	2011-12-06	2013-09-04	富田製薬株式会社	重炭酸透析剤
SG11201910175RA (en) *	2017-05-05	2019-11-28	Fresenius Medical Care Deutschland Gmbh	Peritoneal dialysis concentrate, peritoneal dialysis bag and set for continuous ambulatory peritoneal dialysis or automated peritoneal dialysis
CN114460202A (zh) *	2022-02-11	2022-05-10	山东威高肾科医疗器械有限公司	一种血液透析液中葡萄糖浓度的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4784495A (en)	1987-02-06	1988-11-15	Gambro Ab	System for preparing a fluid intended for a medical procedure by mixing at least one concentrate in powder form with water
ATE105712T1 (de)	1990-01-12	1994-06-15	Nephro Medica Pharma	Bicarbonat und calcium enthaltende infusions- und dialysierlösung.
DK0671166T3 (da) *	1991-04-26	2005-01-03	Mitsubishi Pharma Corp	Næringstilförende præparater
ES2149793T5 (es)	1993-02-19	2005-03-01	Wilfried Dr.-Ing. Schal	Procedimiento para la preparacion de liquido dializador bicarbonatado para la hemodialisis.
IT1263967B (it)	1993-02-24	1996-09-05		Soluzioni per dialisi peritoneale
KR960000223A (ko)	1994-06-08	1996-01-25	김정순	신규한 피리돈 카르복실산 화합물을 함유한 수용액 및 이의 제조방법
DE19631124A1 (de) *	1996-08-01	1998-02-05	Fresenius Medical Care De Gmbh	Verfahren zur Herstellung einer Bicarbonat enthaltenden Infusions- oder Dialysierlösung

1997
- 1997-10-07 SE SE9703650A patent/SE510587C2/sv not_active IP Right Cessation
1998
- 1998-10-05 ES ES98948026T patent/ES2183417T3/es not_active Expired - Lifetime
- 1998-10-05 AT AT98948026T patent/ATE227985T1/de not_active IP Right Cessation
- 1998-10-05 JP JP2000514633A patent/JP4346818B2/ja not_active Expired - Fee Related
- 1998-10-05 WO PCT/SE1998/001785 patent/WO1999017762A1/en not_active Ceased
- 1998-10-05 US US09/529,213 patent/US6323182B1/en not_active Expired - Lifetime
- 1998-10-05 AU AU94689/98A patent/AU9468998A/en not_active Abandoned
- 1998-10-05 DE DE69809587T patent/DE69809587T2/de not_active Expired - Lifetime
- 1998-10-05 EP EP98948026A patent/EP1033984B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE69809587D1 (de)	2003-01-02
ES2183417T3 (es)	2003-03-16
US6323182B1 (en)	2001-11-27
EP1033984A1 (de)	2000-09-13
EP1033984B1 (de)	2002-11-20
SE9703650D0 (sv)	1997-10-07
ATE227985T1 (de)	2002-12-15
JP2001518497A (ja)	2001-10-16
WO1999017762A1 (en)	1999-04-15
JP4346818B2 (ja)	2009-10-21
AU9468998A (en)	1999-04-27
SE9703650L (sv)	1999-04-08
DE69809587T2 (de)	2003-03-27

Legal Events

Date	Code	Title	Description
2005-05-31	NUG	Patent has lapsed

Publication	Publication Date	Title
SE510587C2 (sv)	1999-06-07	Koncentrat för dialyslösning och användning därav
ES2677603T3 (es)	2018-08-03	Composición precursora de diálisis
JP5840017B2 (ja)	2016-01-06	透析用製剤
KR101831007B1 (ko)	2018-02-21	투석 전구체 조성물
US4308255A (en)	1981-12-29	Balanced oncotic pressure fluid
JP5505577B1 (ja)	2014-05-28	ペクチン水溶液
EP2720678B1 (de)	2020-10-21	Dialysevorläuferzusammensetzung
EP2720700B1 (de)	2016-06-01	Dialyse vormischung
JP5204359B2 (ja)	2013-06-05	透析用剤およびその製造方法
CN104271173A (zh)	2015-01-07	用于确定医用液体组合物中电解质和非电解质的比例的方法和装置
CN104622896A (zh)	2015-05-20	一种钠钾镁钙葡萄糖注射液的制备方法
JP2002527482A (ja)	2002-08-27	透析用緩衝化組成物
EP2793902B1 (de)	2018-05-30	Dialysevorläuferzusammensetzung
CN112088898A (zh)	2020-12-18	一种含氧化还原电位水的组合物及其制备方法
JPH02304026A (ja)	1990-12-17	腹腔洗浄液
JP2003339853A (ja)	2003-12-02	安定な透析用剤
EP0208709A1 (de)	1987-01-21	Bakteriostatisches hämodialysekonzentrat
JP3947995B2 (ja)	2007-07-25	重炭酸固形透析用剤
JPH09301875A (ja)	1997-11-25	血液透析製剤
CN114306345A (zh)	2022-04-12	复合维生素b制剂的原料组合物、复合维生素b制剂及其制备方法和应用
JP6985937B2 (ja)	2021-12-22	有機リン酸エステルを含有する透析液または置換液
CN113456667A (zh)	2021-10-01	一种高纯度血液透析浓缩液及制备工艺
JP2016131510A (ja)	2016-07-25	水分電解質補給飲料用粉末組成物
JP2008246209A (ja)	2008-10-16	透析用剤およびその製造方法
CN103536528B (zh)	2015-04-01	一种核黄素磷酸钠注射液及其制备工艺